IMpella-Protected cArdiaC Surgery Trial (IMPACT)

NAActive, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 21, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Left Ventricular Dysfunction
Interventions
DEVICE

Impella 5.5 with SmartAssist

For subjects enrolled in the Trial, the Impella 5.5 will be placed intra-operatively during the index cardiac surgical procedure

Trial Locations (20)

10016

NYU Langone Health, New York

10032

New York- Presbyterian Hospital/ Columbia University Medical Center, New York

10467

Montefiore Medical Center, The Bronx

19104

Hospital of The University of Pennsylvania, Philadelphia

28401

New Hanover Regional Medical Center, Wilmington

30322

Emory University Hospital, Atlanta

34102

NCH Rooney Heart Institute, Naples

37203

Centennial Heart Cardiovascular, Nashville

44195

Cleveland Clinic Foundation, Cleveland

55407

Minneapolis Heart Institute Foundation/Abbott Northwestern Hospital, Minneapolis

63110

Barnes-Jewish Hospital, St Louis

72401

Cardiology Associates Research Group, Jonesboro

75093

Baylor Scott and White - Plano, Plano

78705

University of Texas Austin Dell Medical School/Ascension Texas, Austin

90033

Keck School of Medicine, Los Angeles

92056

Tri-City Medical Center, San Diego

97225

Providence St. Vincent Medical Center, Portland

02114

Mass General Hospital, Boston

02115

Brigham & Women's, Boston

07601

Hackensack University Medical Center, Hackensack

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abiomed Inc.

INDUSTRY